Citigroup
CCXI

Citigroup’s ChemoCentryx, Inc. CCXI Stock Holding History

Citigroup’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-29,000
Closed -$727K – 6869
2022
Q1 		$727K Buy
+29,000
New +$815K ﹤0.01% 3231

Other funds holding CCXI

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citigroup's CCXI Position: Q4 2022 in Review

Citigroup sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 141,170 shares — an estimated $7.29M sold.

Citigroup first reported a position in CCXI in Q2 2013 and held it in 37 quarters. The position peaked at $11.9M in Q2 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Citigroup reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Citigroup sold 141,170 ChemoCentryx, Inc. shares in Q4 2022, an estimated $7.29M.
  • Citigroup first reported a position in ChemoCentryx, Inc. in Q2 2013 and held it in 37 quarters.
  • Citigroup's ChemoCentryx, Inc. position peaked at $11.9M in Q2 2020.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Citigroup's 13F filing for Q4 2022, filed 9 Feb 2023.